IRDVSNGNE• 3 Months (Normalized)
IRD vs NGNE (Opus Genetics Inc. vs Neurogene Inc.)
Showing Closing Date Range from Jun, 18 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
IRD Performance $5.41
+32.92%
Opus Genetics Inc.
Normalized Baseline0.00%
NGNE Performance $34.67
+9.96%
Neurogene Inc.
Normalized Baseline0.00%
Alpha Spread Margin IRD LEADS
+22.96%
IRD outperforming by 22.96%
IRDNGNE
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
IRD NGNE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | IRD Price | IRD Gain (%) | NGNE Price | NGNE Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $5.41 | +32.92% | $34.67 | +9.96% | +22.96% |
| Sep 15, 2026 | $5.82 | +43.00% | $33.69 | +6.85% | +36.15% |
| Sep 14, 2026 | $5.97 | +46.68% | $35.21 | +11.67% | +35.01% |
| Sep 11, 2026 | $6.04 | +48.40% | $35.48 | +12.53% | +35.87% |
| Sep 10, 2026 | $6.07 | +49.14% | $36.12 | +14.56% | +34.58% |
| Sep 09, 2026 | $5.73 | +40.79% | $37.88 | +20.14% | +20.65% |
| Sep 08, 2026 | $4.34 | +6.63% | $38.13 | +20.93% | -14.30% |
| Sep 04, 2026 | $4.67 | +14.74% | $38.60 | +22.42% | -7.68% |
| Sep 03, 2026 | $4.60 | +13.02% | $37.61 | +19.28% | -6.26% |
| Sep 02, 2026 | $4.45 | +9.34% | $38.36 | +21.66% | -12.32% |
| Sep 01, 2026 | $3.83 | -5.90% | $37.87 | +20.11% | -26.01% |
| Aug 31, 2026 | $3.62 | -11.06% | $36.24 | +14.94% | -26.00% |
| Aug 28, 2026 | $3.69 | -9.34% | $36.58 | +16.02% | -25.36% |
| Aug 27, 2026 | $3.85 | -5.41% | $37.86 | +20.08% | -25.49% |
| Aug 26, 2026 | $3.80 | -6.63% | $38.41 | +21.82% | -28.45% |
Page 1 of 5